GlassScriptPhysician profile
Charles W Nelson
NPI 1639194913
$1,096.28
in general payments reported to CMS, 2019-2025
18 companies · $80.14 in 2025
The $80.14 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $97.79 · 2021: $20.26 · 2022: $154 · 2023: $47.27 · 2024: $489 · 2025: $80.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $451 · Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $450.75 |
| Food and Beverage | $165.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $450.75 | 2024 | Mako |
| Medtronic Vascular, INC. | $116.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $78.99 | 2022-2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $74.37 | 2019-2022 | |
| Astellas Pharma US INC | $73.83 | 2019-2020 | |
| Pfizer INC. | $64.33 | 2019-2022 | |
| Novo Nordisk INC | $34.15 | 2020-2024 | Ozempic, Rybelsus |
| Philips North America LLC | $32.84 | 2025 | Extended Holter |
| Heartflow, INC. | $27.95 | 2025 | |
| Atricure, INC. | $20.26 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.35 | 2025 | Lifevest |
| Vital Connect, INC | $19.18 | 2023 | Vitalpatch Rtm |
| Abiomed | $15.69 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.01 | 2022 | |
| Amgen INC. | $14.87 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.70 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.24 | 2019 | |
| Merck Sharp & Dohme LLC | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.